Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04015219 · ClinicalTrials.gov registry record · NA
Management of Signs and Symptoms Associated With Dry Eye Disease
A NA study, sponsored by BioTissue Holdings.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04015219 is a NA study that was terminated before completion, run by BioTissue Holdings. The registered enrollment target is 3 participants.
The verdict
NCT04015219, a NA study, was terminated before completion, sponsored by BioTissue Holdings.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
A prospective randomized, and controlled study to compare the effectiveness of PROKERA® SLIM plus standard of care (SOC) in the PROKERA® SLIM Arm to SOC alone in the Control Arm. Subjects presenting with moderate DED defined as corneal fluorescein staining score of ≥ 3 points out of 9 will be recruited.
Interventions
- DEVICE Self retained cryopreserved amniotic membrane
- OTHER lifitegrast ophthalmic solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-07-18 |
| Est. Completion | 2020-10-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04015219
The ClinicalTrials.gov registry entry for NCT04015219 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioTissue Holdings, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Self retained cryopreserved amniotic membrane is the first listed.
NCT04015219 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04015219 about?
NCT04015219 is a clinical study titled "Management of Signs and Symptoms Associated With Dry Eye Disease". A prospective randomized, and controlled study to compare the effectiveness of PROKERA® SLIM plus standard of care (SOC) in the PROKERA® SLIM Arm to SOC alone in the Control Arm. Subjects presenting with moderate DED defined as corneal fluorescein staining score of ≥ 3 points out of 9 will be recrui...
What is the current status of trial NCT04015219?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2018-07-18. Estimated completion is 2020-10-05.
What interventions are being tested in trial NCT04015219?
The interventions under investigation include: Self retained cryopreserved amniotic membrane (DEVICE), lifitegrast ophthalmic solution (OTHER).
Who is sponsoring clinical trial NCT04015219?
This trial is sponsored by BioTissue Holdings, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.